Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice.
Saved in:
| Title: | Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice. |
|---|---|
| Authors: | Debourdeau, Eloi1,2 (AUTHOR) e-debourdeau@chu-montpellier.fr, Beylerian, Helene1 (AUTHOR), Nguyen, Vuong3 (AUTHOR), Barthelmes, Daniel3,4 (AUTHOR), Gillies, Mark3 (AUTHOR), Gabrielle, Pierre Henry5 (AUTHOR), Vujosevic, Stela6 (AUTHOR), Otoole, Louise7 (AUTHOR), Puzo, Martin8 (AUTHOR), Creuzot-Garcher, Catherine5 (AUTHOR), Wolff, Benjamin9 (AUTHOR), Daien, Vincent1,2,3 (AUTHOR), Cohn, A. (AUTHOR), Marsh, Bacchus (AUTHOR), Jaross, N. (AUTHOR), Barry, R. (AUTHOR), McLean, I. (AUTHOR), Guillaumie, T. (AUTHOR), Miri, A. (AUTHOR), Gabrielle, P. (AUTHOR) |
| Source: | Ophthalmology & Therapy. Sep2024, Vol. 13 Issue 9, p2343-2355. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21938245 |
|---|---|
| DOI: | 10.1007/s40123-024-00983-2 |
